Oxford Nanopore Technologies plc (LON:ONT)

Market Cap	1.19B +33.7%
Revenue (ttm)	223.90M +22.2%
Net Income	-145.20M
EPS	-0.15
Shares Out	967.10M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,246,814
Average Volume	1,729,134
Open	126.00
Previous Close	124.70
Day's Range	122.70 - 127.50
52-Week Range	96.35 - 224.80
Beta	0.83
RSI	44.67
Earnings Date	Mar 2, 2026

About LON:ONT

Oxford Nanopore Technologies plc engages in the research, development, manufacture, and commercialization of a novel generation of deoxyribonucleic acid (DNA) or ribonucleic acid (RNA) sequencing technology that allows the real-time analysis of DNA or RNA. It offers MinION Mk 1D, a portable device for DNA and RNA; GridION and GridION Q, a compact bench top device, which delivers a version of hardware, software, and chemistry. The company also provides PromethION 2 Solo, PromethION 2, PromethION 24, and PromethION 48. Its platform enables its cu...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2005
• Employees: 1,335
• Stock Exchange: London Stock Exchange
• Ticker Symbol: ONT

Financial Performance

In 2025, LON:ONT's revenue was 223.90 million, an increase of 22.22% compared to the previous year's 183.19 million. Losses were -145.20 million, -0.68% less than in 2024.